Assessment of subclinical atherosclerosis and cardiovascular risk

R M Benitez1, R A Vogel

  • 1Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA. MBenitez@medicine.umaryland.edu

Clinical Cardiology
|October 12, 2001
PubMed

Insights

Conventional cardiac risk factors are insufficient for predicting coronary artery disease. Newer imaging and serum markers complement traditional methods for better risk stratification and patient selection for interventions.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Medical Imaging

Background:

  • Conventional risk factors inadequately predict coronary artery disease (CAD) incidence and events.
  • Sole reliance on traditional risk factors may miss individuals who could benefit from interventions.
  • A significant gap exists in identifying all at-risk populations for cardiovascular disease.

Purpose of the Study:

  • To review the complementary roles of newer risk stratification methods alongside conventional factors.
  • To enhance the identification of individuals and populations at increased risk for coronary events.
  • To integrate advanced diagnostics into cardiovascular risk assessment strategies.

Main Methods:

  • Review of noninvasive imaging techniques for atherosclerosis detection in coronary and extracoronary arteries.
  • Evaluation of novel non-traditional serum markers for cardiovascular risk assessment.
  • Synthesis of findings in the context of established cardiovascular risk factor assessment.

Main Results:

  • Noninvasive imaging of atherosclerosis provides valuable risk information beyond traditional factors.
  • Non-traditional serum markers offer additional insights into an individual's cardiovascular risk profile.
  • Combining newer methods with conventional factors improves the accuracy of risk stratification.

Conclusions:

  • Newer risk stratification tools, including advanced imaging and biomarkers, are essential complements to traditional risk factors.
  • Integrated risk assessment strategies can identify a broader spectrum of individuals benefiting from cardiovascular risk reduction.
  • Improved identification of at-risk populations can optimize the application of lifestyle and therapeutic interventions.

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...